Viewing StudyNCT04783935



Ignite Creation Date: 2024-05-06 @ 3:51 PM
Last Modification Date: 2024-10-26 @ 1:58 PM
Study NCT ID: NCT04783935
Status: COMPLETED
Last Update Posted: 2024-04-23
First Post: 2021-03-03

Brief Title: Extension to the MAGNIFY MS Trial on Mavenclad Magnify MS Extension
Sponsor: Merck Healthcare KGaA Darmstadt Germany an affiliate of Merck KGaA Darmstadt Germany
Organization: Merck Healthcare KGaA Darmstadt Germany an affiliate of Merck KGaA Darmstadt Germany

Conditions & Keywords Data

Conditions:
Name
Multiple Sclerosis
Keywords:
Name View
Multiple Sclerosis View
Mavenclad View
Cladribine View
Relapsing Multiple Sclerosis View
Immune cell kinetics View